Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ricerca Biosciences | Contract Pharma
Breaking News, Promotions & Moves

Ricerca Biosciences

William DeMaio, Ph.D., has been named senior director of the drug metabolism and pharmacokinetics (DMPK) department at Ricerca Biosciences.

William DeMaio, Ph.D., has been named senior director of the drug metabolism and pharmacokinetics (DMPK) department at Ricerca Biosciences. Dr. DeMaio joins a team of bioanalytical and drug metabolism scientists that offers support for Ricerca’s discovery and preclinical development programs.

“Dr. DeMaio has an international reputation as one of the pharmaceutical industry’s best mass spectrometrists and metabolism scientists,” stated Dr. Michael Placke, senior vice president and general manager of Ricerca’s Concord, OH, drug development operations. “Bill has solved most challenges one is likely to encounter in characterizing drug product exposure and metabolizing identification in both non-clinical and clinical settings.”

Prior to joining the company, Dr. DeMaio was associate director of biotransformation at Wyeth Research in Collegeville, PA, where he was responsible for drug metabolite identification and metabolism characterization by mass spectrometry. Dr. DeMaio has expertise in chromatography, mass spectrometry, structural elucidation and drug development, as well as operating GLP-compliant bioanalytical and metabolism operations and training analysts in use of LC/MS equipment and data analysis.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters